Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Bzip in-frame mutations might abrogate the adverse prognosis of therapy-related CEBPA-mutated AML

View Full Paper
Ask AI
Bookmark
Share

Authors

GCGuanghui ChangHGHaitao GaoXZXiao‐Su Zhao

Discussion

Loading...

Member takes

Overview

Observational analysis highlights prognostic similarities in acute myeloid leukemia variants, suggesting mutation impact on survival.

Key Points

  • t-CEBPA AML shows a poor overall survival rate compared to dn-CEBPA AML.
  • Patients with t-CEBPA AML and t-AML had similar mutations but different outcomes in overall survival metrics.
  • Analysis of survival data indicated significant gains with allogeneic hematopoietic stem cell transplantation in t-CEBPA AML.
  • Survival rates of t-CEBPA AML showed notable risk factors, including TP53 mutations and overall survival implications.

Cite This Study

Chang et al. (2025) studied this question.

synapsesocial.com/papers/69362f484fa91c937236d68dhttps://doi.org/10.1182/blood-2025-5163
View Full Paper
Ask AI
Bookmark
Share